Navigation Links
Building memories with actin
Date:7/13/2009

Memories aren't made of actin filaments. But their assembly is crucial for long-term potentiation (LTP), an increase in synapse sensitivity that researchers think helps to lay down memories. In the July 13, 2009 issue of the Journal of Cell Biology (www.jcb.org), Rex et al. reveal that LTP's actin reorganization occurs in two stages that are controlled by different pathways, a discovery that helps explain why it is easy to encode new memories but hard to hold onto them.

If you can't seem to forget those ABBA lyrics you heard in seventh grade but can't remember Lincoln's Gettysburg address, the vagaries of LTP might be to blame. Neuroscientists think that the process, in which a brain synapse becomes more potent after repeated stimulation, underlies the formation and stabilization of new memories. LTP involves changes in the anatomy of synapses and dendritic spines, a process that depends on reorganization of the supporting actin cytoskeleton. However, researchers didn't know what controlled these changes.

Rex et al. tackled the question by dosing slices of rat hippocampus with adenosine, a naturally occurring signal that squelches LTP. Adenosine prevents phosphorylation and inactivation of cofilin, an inhibitor of actin filament assembly, the team found. Cofilin's involvement, in turn, implicates signaling cascades headed by GTPases, such as the RhoA-ROCK and Rac-PAK pathways. The researchers showed that a ROCK inhibitor stalled actin polymerization and resulted in a short-lived LTP. A Rac-blocking compound had no effect.

That doesn't mean the Rac-PAK pathway isn't involved in LTP, however. The team discovered that the Rac inhibitor prolonged cells' vulnerability to a molecule that prevents the stabilization of new actin filaments. That result led Rex et al. to conclude that the two pathways exert their effects at different points. The Rho-ROCK pathway initiates the cytoskeletal changes of LTP, and the Rac-PAK pathway solidifies them so that heightened synapse sensitivity can persist. The researchers hypothesize that one pathway encodes memories, while the other makes sure they stick around.


'/>"/>

Contact: Rita Sullivan
news@rupress.org
212-327-8603
Rockefeller University Press
Source:Eurekalert  

Related biology news :

1. Building blocks of life
2. Rebuilding the evolutionary history of HIV-1 unravels a complex loop
3. Building blocks of life formed on Mars
4. Building disease-beating wheat
5. Building the future -- 21st century nano tools to repair the nervous system
6. International workshop to address capacity building for rainforest leaders
7. In Todays Economy, You Can Strengthen Your Company by Building Your Brand
8. Scientists make chemical cousin of DNA for use as new nanotechnology building block
9. UCI awarded $27.2 million for new stem cell building
10. Building on pyramids of trash
11. Manchester clears first hurdle in €170 million biobank building boom
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Building memories with actin
(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
(Date:1/24/2017)... 2017 Biopharm Reports has carried out ... of nuclear magnetic resonance spectroscopy (NMR). This involved ... current practices, developments, trends and end-user plans over ... and opportunities. These areas include growth in the ... and innovation requirements, hyphenated NMR techniques, main suppliers ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, ... focused on venture growth investments in biotechnology and ... Josh Richardson , M.D. to Managing Director. ... companies.  He is a board observer at InfaCare ... Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence ...
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... the infusion of innovative telemedicine application, new and ... that are experiencing a boom worldwide. The healthcare ... advancement of technologies, services and new therapies for ... RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology: